---
schema_version: "secwatch.filing_event.v1"
accession: "0001829126-22-017024"
form_type: "8-K/A"
ticker: "NXL"
cik: "0001527352"
company_name: "Nexalin Technology, Inc."
filed_at: "2022-09-20T23:59:59+00:00"
generated_at: "2026-06-23T08:30:34.028294+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Nexalin Technology closes $9.6M IPO; shares and warrants begin trading on Nasdaq

## Summary
- Closed IPO of 2,315,000 units at $4.15/unit (1 share + 1 warrant); gross proceeds $9.6M, net $8.7M.
- Warrants exercisable at $4.15 for 3 years (until Sept 19, 2025); redeemable at $0.01 if stock >$12.45 for 20 of 30 days.
- Maxim Group partially exercised overallotment, purchasing 347,250 warrants.
- Gen-2 neurostimulation device approved in China by NMPA for insomnia and depression.
- Shares (NXL) and warrants (NXLIW) began trading on Nasdaq on Sept 16, 2022.

## SEC filing metadata
- accession: 0001829126-22-017024
- form_type: 8-K/A
- ticker: NXL
- cik: 0001527352
- company_name: Nexalin Technology, Inc.
- filed_at: 2022-09-20T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1527352/000182912622017024/0001829126-22-017024-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1527352/000182912622017024/nexalintech_8ka1.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001829126-22-017024
- JSON: https://secwatch.observer/filing/0001829126-22-017024.json
- Plain text: https://secwatch.observer/filing/0001829126-22-017024.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.